Subsidy Tracker Parent Company Summary

Parent Company Name: 
Gilead Sciences
Ownership Structure: 
publicly traded (ticker symbol GILD)
Headquartered in: 
California
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$12,519,60726
Federal (grants and allocated tax credits)$00
TOTAL$12,519,60726
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$4,500,0001
TOTAL$4,500,0001
Time Period for State and Local Awards: 

Earliest year of data: 2007. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2013.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

GILEAD SCIENCES; KITE PHARMA

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of political contributions associated with this company, see its Follow the Money page.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
California$9,182,2454
North Carolina$2,134,8528
Washington$1,202,51014

Individual Subsidy Records:

Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
Kite Pharma, Inc. California state 2016 $7,000,000 tax credit/rebate
Kite Pharma, Inc. California state 2015 $1,800,000 tax credit/rebate
Gilead Sciences, Inc. North Carolina state 2011 $550,523 tax credit/rebate
Gilead Sciences, Inc. North Carolina state 2013 $547,098 tax credit/rebate
Gilead Sciences, Inc. North Carolina state 2013 $547,098 tax credit/rebate
GILEAD SCIENCES INC Washington state 2014 $403,872 tax credit/rebate
Gilead Sciences, Inc. North Carolina state 2015 $319,628 tax credit/rebate
GILEAD SCIENCES INC California state 2015 $191,250 training reimbursement
GILEAD SCIENCES, INC. California state 2011 $190,995 training reimbursement
Gilead Sciences, Inc. North Carolina state 2016 $162,288 tax credit/rebate
GILEAD SCIENCES INC Washington state 2013 $141,588 tax credit/rebate
GILEAD SCIENCES INC Washington state 2012 $108,730 tax credit/rebate
GILEAD SCIENCES INC Washington state 2011 $83,248 tax credit/rebate
GILEAD SCIENCES INC Washington state 2010 $72,840 tax credit/rebate
GILEAD SCIENCES INC Washington state 2008 $71,546 tax credit/rebate
GILEAD SCIENCES INC Washington state 2009 $66,838 tax credit/rebate
GILEAD SCIENCES INC Washington state 2007 $63,676 tax credit/rebate
GILEAD SCIENCES INC Washington state 2013 $41,681 tax credit/rebate
GILEAD SCIENCES INC Washington state 2014 $41,681 tax credit/rebate
GILEAD SCIENCES INC Washington state 2015 $41,681 tax credit/rebate
GILEAD SCIENCES INC Washington state 2016 $41,681 tax credit/rebate
GILEAD SCIENCES INC Washington state 2011 $11,724 tax credit/rebate
GILEAD SCIENCES INC Washington state 2012 $11,724 tax credit/rebate
Gilead Palo Alto, Inc. North Carolina state 2011 $3,743 tax credit/rebate
Gilead Palo Alto, Inc. North Carolina state 2013 $2,237 tax credit/rebate
Gilead Palo Alto, Inc. North Carolina state 2013 $2,237 tax credit/rebate
Gilead Sciences, Inc. United States federal 2011 $4,500,000 federal loan or loan guarantee
KITE PHARMA INC California local 2012 undisclosed tax credit/rebate
Download results as CSV or XML